Interleukin-12 Antagonist
- Name
- Interleukin-12 Antagonist
- Accession Number
- DBCAT003459 (DBCAT004458)
- Description
Not Available
- Drugs
Drug Drug Description Ustekinumab A targeted antibody therapy used to manage inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis. - Drugs & Drug Targets
Drug Target Type Ustekinumab Interleukin-12 subunit beta target Ustekinumab Interleukin-23 target